An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic ...
Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...
September 13, 2009 (San Francisco, California) — Universal screening using rapid polymerase chain reaction (PCR) analysis for methicillin-resistant Staphylococcus aureas (MRSA) in hospitals appears to ...
bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...
Results from focus groups and questionnaires showed healthcare workers from Chicago-area hospitals generally exhibited positive perceptions toward legislation requiring MRSA screening, according to ...
Nasal screening for methicillin-resistant Staphylococcus aureus (MRSA) serves as a cornerstone for infection prevention and antimicrobial stewardship. The anterior nares are the primary reservoir for ...
Bacterial Infections: April 2006 Dr. John G. Bartlett reviews the literature on the epidemiology of invasive pneumococcal disease in the era of vaccination; nasal carriage of MSSA and MRSA; and UTI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results